AngioDynamics (FRA:UG2) OCF Margin %: -3.97% (As of Feb. 2026)

What is AngioDynamics OCF Margin %?

AngioDynamics FRA:UG2 -0.92% 62 OCF Margin % is -3.97% as of Feb. 2026. GuruFocus rates FRA:UG2 with a GF Score™ of 62/100 and a GF Value™ of €7.27. The stock has 7 warning signs investors should review. Among 815 Medical Devices & Instruments companies, AngioDynamics ranks worse than 59.02% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. AngioDynamics's Cash Flow from Operations for the three months ended in Feb. 2026 was €-2.6 Mil. AngioDynamics's Revenue for the three months ended in Feb. 2026 was €66.3 Mil. Therefore, AngioDynamics's OCF Margin % for the quarter that ended in Feb. 2026 was -3.97%.

As of today, AngioDynamics's current OCF Yield % is 0.87%.

The historical rank and industry rank for AngioDynamics's OCF Margin % or its related term are showing as below:

FRA:UG2' s OCF Margin % Range Over the Past 10 Years
Min: -9.27 Med: 4.15 Max: 20.66
Current: 1.63

During the past 13 years, the highest OCF Margin % of AngioDynamics was 20.66%. The lowest was -9.27%. And the median was 4.15%.

FRA:UG2's OCF Margin % is ranked worse than
59.02% of 815 companies
in the Medical Devices & Instruments industry
Industry Median: 5.86 vs FRA:UG2: 1.63

AngioDynamics OCF Margin % Related Terms

AngioDynamics OCF Margin % Historical Data

* Premium members only.

The historical data trend for AngioDynamics's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AngioDynamics OCF Margin % Chart

AngioDynamics Annual Data

Trend

May16

May17

May18

May19

May20

May21

May22

May23

May24

May25

OCF Margin %

Get a 7-Day Free Trial

8.28

-2.28

0.02

-9.27

-3.46

AngioDynamics Quarterly Data
	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24	Nov24	Feb25	May25	Aug25	Nov25	Feb26
OCF Margin %	Get a 7-Day Free Trial															-18.28	23.47	-21.02	5.87	-3.97

FRA:UG2 vs OSUR, UTMD, SMTI: OCF Margin % Comparison

For the Medical Instruments & Supplies subindustry, AngioDynamics's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

AngioDynamics OCF Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, AngioDynamics's OCF Margin % distribution charts can be found below:

* The bar in red indicates where AngioDynamics's OCF Margin % falls into.

Save Embed

62GF Score

AngioDynamics Inc FRA:UG2

OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

AngioDynamics OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

AngioDynamics's OCF Margin for the fiscal year that ended in May. 2025 is calculated as

OCF Margin	=	Cash Flow from Operations (A: May. 2025 )	/	Revenue (A: May. 2025 )
	=	-8.984	/	259.446
	=	-3.46 %

AngioDynamics's OCF Margin for the quarter that ended in Feb. 2026 is calculated as

OCF Margin	=	Cash Flow from Operations (Q: Feb. 2026 )	/	Revenue (Q: Feb. 2026 )
	=	-2.631	/	66.346
	=	-3.97 %

Frequently Asked Questions Learn more about OCF Margin % →

What does a OCF Margin % of -3.97% mean?

AngioDynamics (FRA:UG2) has a OCF Margin % of -3.97% as of Feb. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on AngioDynamics and its competitors. According to the industry distribution chart, AngioDynamics ranks #481 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 59%.

Is AngioDynamics' OCF Margin % too high?

AngioDynamics' current OCF Margin % is -3.97%. Based on the distribution chart, AngioDynamics ranks #481 out of 815 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, AngioDynamics has a GF Score™ of 62/100, reflecting its overall financial health beyond just this single metric.

How does AngioDynamics' OCF Margin % compare to OSUR and UTMD?

According to the Medical Devices & Instruments industry distribution chart, AngioDynamics ranks #481 out of 815 companies for OCF Margin %. This places AngioDynamics in the lower half of its industry. The industry median OCF Margin % is 5.86. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good OCF Margin % for a Medical Devices & Instruments company?

The median OCF Margin % among Medical Devices & Instruments companies is 5.86, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high OCF Margin % mean?

A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on AngioDynamics and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 5.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. AngioDynamics's current OCF Margin % is -3.97%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is AngioDynamics stock overvalued right now?

AngioDynamics (FRA:UG2) has a current OCF Margin % of -3.97%. The stock's GF Value™ is €7.27, compared to a current price of €10.80 — trading 48.6% above its estimated fair value. The current OCF Margin % is -3.97%. AngioDynamics' overall GF Score™ is 62/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is OCF Margin % calculated?

OCF Margin % is calculated from a company's financial statements. For AngioDynamics (FRA:UG2), the current OCF Margin % is -3.97% as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is AngioDynamics (FRA:UG2) Overvalued in 2026?

Based on GuruFocus' analysis, AngioDynamics stock appears to be overvalued. The current stock price of €10.80 is trading 48.6% above its estimated GF Value™ of €7.27.

Key valuation signals for FRA:UG2:

OCF Margin %: -3.97%
GF Value™: €7.27 vs. price of €10.80 (48.6% above fair value)
GF Score™: 62/100 with 7 warning signs

No single metric tells the full story. See the FRA:UG2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

AngioDynamics Business Description

Industry Healthcare Medical Devices & Instruments

Comparable Companies OSUR UTMD SMTI PDEX EMBC STXS KRMD MBOT DXR POCI ISRG XPAR:EL TSE:7741 BDX XSWX:ALC MDLN RMD WST TSE:4543 XPAR:DIM

Other Exchanges ANGO:USA

Address 14 Plaza Drive, Latham, NY, USA, 12110

Website https://www.angiodynamics.com

AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.

62GF Score

Get the complete analysis for FRA:UG2

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€10.80

Price

€7.27

GF Value

View FRA:UG2 Analysis

See OCF Margin % data for all stocks →